India's Largest Database on New Projects
Fortis teams up with TotipotentRX for stem cell research
15 March 2011: Fortis Healthcare (India) has joined hands with California based TotipotentRX Cell Therapy to set up centres of excellence offering cellular therapies and stem cell clinical trials, across select Fortis hospitals.
These centres will undertake stem cell clinical research procedures relating to diabetes, cancer, cardiovascular disease, and neurological ischemia. TotipotentRX will also set up laboratories in select hospitals, for processing stem cells before transplantation to patients. TotipotentRX will leverage Fortis' hospital network and respective areas of clinical expertise to investigate new regenerative therapies, using promising adult stem cell sources such as cord blood, bone marrow, and adipose tissue.
Source: Hindu Business Line